Comparison of dideoxynucleoside drugs (DDI and zidovudine) and induction of hematopoietic toxicity using normal human bone marrow cells in vitro
Authors:
- 1 February 1993
- journal article
- research article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 15 (2) , 263-268
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Effect of Interleukin-1, GM-CSF, Erythropoietin, and Lithium on the Toxicity Associated With 3′-Azido-3′-Deoxythymidine (AZT) In Vitro on Hematopoietic Progenitors (CFU-GM, CFU-MEG, and BFU-E) Using Murine Retrovirus-Infected Hematopoietic CellsJournal of Leukocyte Biology, 1991
- Effect of IL-1, IL-6, GM-CSF and Erythropoietin on the in vitro Toxicity Associated with AZT on Human Bone Marrow Haematopoietic Progenitor Stem Cells: CFU-GM and BFU-EAntiviral Chemistry and Chemotherapy, 1991
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Developmental Therapeutics and the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1987
- Strategies for antiviral therapy in AIDSNature, 1987
- Suppression of mouse viraemia and retroviral disease by 3′-azido-3′-deoxythymidineNature, 1986
- ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1986